12:00 AM
 | 
Feb 10, 2014
 |  BC Week In Review  |  Company News  |  Deals

InSite, Bess Royalty, SWK Holdings deal

InSite said it received a $1 million milestone payment from Bess Royalty and the SWK Funding LLC subsidiary of SWK due to 2013 net sales of Besivance besifloxacin ophthalmic solution reaching undisclosed levels. Last April, InSite sold its royalty on Besivance sales...

Read the full 207 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >